mortality/aging
• 50% of mice die by 7 months
(J:53451)
• early moridity in mice treated with DES
(J:98929)
• death at 161-164 days in treated mice
(J:98929)
• death at 297-299 days for untreated mice
(J:98929)
|
reproductive system
azoospermia
(
J:33878
)
|
• oocytes do not complete meiosis II
|
• arrest at pachytene
|
small testis
(
J:33878
)
|
neoplasm
• 72% of mice develop tumors
|
• 33% of mice develop gastrointestinal tumors in the stomach, duodenum, jejunum, ileum, and colon
|
• 50% of mice develop adenomas
|
• some mice develop non-Hodgkin's lymphoma (5 of 8 T cell type, 2 of 8 B cell type) and Hodgkin's lymphoma
|
• 5 of 8
|
• 2 of 8
(J:53451)
• five of eight lymphomas tested are B cell lymphomas
(J:98929)
|
• mice develop 13% carcinomas and 37% early invasive carcinomas
• one mouse develops sweat gland carcinoma
|
cellular
azoospermia
(
J:33878
)
|
• oocytes do not complete meiosis II
|
• arrest at pachytene
|
• apoptosis of arrested germ cells
|
endocrine/exocrine glands
• 5 of 8
|
small testis
(
J:33878
)
|
digestive/alimentary system
• 33% of mice develop gastrointestinal tumors in the stomach, duodenum, jejunum, ileum, and colon
|
immune system
• 5 of 8
|
hematopoietic system
• 5 of 8
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
Lynch syndrome | DOID:3883 |
OMIM:PS120435 |
J:53451 |